DBS-related infections in Parkinson's disease: Incidence, risk factors, management and outcome.

For my 80th birthday, I bought myself a new brain: my experiences with adaptive deep brain stimulation to assist my Parkinson's disease.

Absorption, distribution, metabolism and excretion of SUL-138 in rats and minipigs.

Parkinson's disease and risk of melanoma in United States Veterans: A Veterans Affairs Cancer Registry retrospective cohort study.

Adenosine A₂A receptor as a dual-acting molecular switch: Glial morphological changes and neurovascular tissue remodeling in neuroinflammation and neurodegeneration.

Surface-enhanced Raman spectroscopy of serum exosomes coupled with support vector machine for diagnosis of Parkinson's disease.

The protective effect of febuxostat in a rotenone mouse model of Parkinson's disease: the interplay between PI3K/Akt/mTOR, GSK-3β, and Nrf2/HO-1 signaling pathways.

Oculomotor abnormalities in patients with cerebellar ataxia, neuropathy, vestibular areflexia syndrome (CANVAS) reflect midline cerebellar impairment.

Risk-Benefit Considerations in Deep Brain Stimulation Discontinuation for Late-Stage Parkinson's Disease.

Mitochondrial DNA: a molecular switch driving sterile neuroinflammation.

MPTP and rotenone cause dopaminergic neuronal death by increasing DDIT4 promoter lactylation.

Unveiling the therapeutic potential of Farnesol against Parkinson's disease: insights from molecular Docking and animal studies.

M1-linked ubiquitination by LUBAC regulates AMPK signalling and the response to energetic stress.

Towards biomarker-based diagnosis of Parkinson disease.

Efficacy of silicon-based agent against aging-related frailty.

Altered cerebrovascular haemodynamics in Parkinson's disease: Insights from 4D flow MRI.

Neuromelanin imaging outperforms free water imaging in diagnosing early Parkinson's disease: a comparative MRI study.

Relationships between alcohol use and dementia: protocol for an observational study in the UK Clinical Practice Research Datalink.

Dysregulated iron homeostasis Drives mitochondrial Injury and ferroptosis susceptibility in MELAS fibroblasts.

Glutamate chemical exchange saturation transfer imaging reveals cerebellar glutamatergic alterations in Parkinson's disease subtypes.

The immunological profile of RC17 hESC-derived dopaminergic neural progenitor cells in vitro: Implications for the STEM-PD clinical trial.

Autoencoder-driven stride length estimation for individuals with Parkinson's disease using inertial measurement unit-embedded footwear.

Discovery of first-in-class melanostatin-based ago-allosteric modulators of the dopamine D(2) receptors.

Perceived Barriers and Facilitators to Radiology Examinations Among Patients with Parkinson's Disease in Ireland.

Neuroimaging correlates of cognitive stages in Parkinson's disease: A multimodal MRI study.

At-home movement state classification using totally implantable cortical-basal ganglia neural interface.

A prospective analysis of falls in Parkinson's disease: Does physical capacity moderate the relationship between walking amount and falls rates?

A Wearable "Lab-in-Shoe" Gait Analysis System for Routine Clinical Assessment of People with Parkinson's Disease.

Web of Potentials: Neuroactive Components of Spider Venom and Their Emerging Pharmacologic Applications in Neurologic Diseases.

Remifentanil-esketamine-based General Anesthesia Strategy for Microelectrode-guided Deep-brain Stimulation for Parkinson Disease.

OTUD6A drives dopaminergic neuronal degeneration of Parkinson's disease through deubiquitinating ACTG1 in neuronal cells.

Wakefulness regulation of memory encoding and retrieval: structure and activity.

Can patient-reported outcome measures predict mortality in neurological populations? A systematic review.

Oridonin attenuates TLR4-driven inflammation and autophagy in LPS-stimulated enteric glial cells: an in vitro and in silico analysis.

Cell-Type-Specific Causal Inference Unveils Novel Targets for Parkinson's Disease.

Local Field Aperiodic Spectral Power Modulated by Deep Brain Stimulation in Parkinson's Disease.

Baseline Regional Cholinergic Denervation Predicts Cognitive Trajectories in Moderate Parkinson Disease.

The Effect of GLP-1 Receptor Agonists on Autophagy: Insights Gathered from Research Evaluating Neurodegenerative Disorders With These Agents.

The Amnesia Light and Brief Assessment (ALBA) and the door PICture Naming and Immediate Recall (PICNIR) brief tests for identifying mild cognitive impairment in Parkinson's disease.

Nrf2-Activating Natural Compounds in Neurodegenerative Diseases: Targeting Oxidative Stress and Protein Aggregation.